Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PeRfusiOn Post tHrombEcTomy (PROPHET) A Prospective Observational Cohort Study

NCT06691230 is registered in ClinicalTrials.gov with Insel Gruppe AG, University Hospital Bern as lead sponsor.

NCT NCT06691230
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06691230 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PeRfusiOn Post tHrombEcTomy (PROPHET) A Prospective Observational Cohort Study
Lead sponsor
Insel Gruppe AG, University Hospital Bern
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2024
Completion date
February 28, 2028
Enrollment
279 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

stroke, acute, ischemic